C. Andrade, “Ketamine for Depression, 1: Clinical Summary of Issues Related to Efficacy, Adverse Effects, and Mechanism of Action,” Journal of Clinical Psychiatry 78, no. 4 (April 2017): e415– e419, doi: 10.4088/JCP.17f11567; M. F. Grunebaum et al., “Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial,” American Journal of Psychiatry 175, no. 4 (April 1, 2018): 327–35, doi: 10.1176/appi.ajp.2017.17060647.
